25-Epi-28-epi-cyasterone

CAS No. 851727-39-4

25-Epi-28-epi-cyasterone( ——— )

Catalog No. M38527 CAS No. 851727-39-4

25-Epi-28-epi-cyasterone (3) is a stereoisomer of cyasterone that can be isolated from Cyathula officinalis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    25-Epi-28-epi-cyasterone
  • Note
    Research use only, not for human use.
  • Brief Description
    25-Epi-28-epi-cyasterone (3) is a stereoisomer of cyasterone that can be isolated from Cyathula officinalis.
  • Description
    25-Epi-28-epi-cyasterone (3) is a stereoisomer of cyasterone that can be isolated from Cyathula officinalis.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    851727-39-4
  • Formula Weight
    520.65
  • Molecular Formula
    C29H44O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Okuzumi K, et al.?
molnova catalog
related products
  • Harmidol hydrochlori...

    Harmalol hydrochloride is a β-carboline alkaloid that can be extracted from the seeds of Peganum harmala L. Harmalol hydrochloride is the major metabolite of Harmaline and significantly inhibits dioxin-mediated induction of CYP1A1 at both transcriptional and post-translational levels.

  • Ursulcholic acid tri...

    Ursulcholic acid trisodium salt (Ursodeoxycholic acid disulfate trisodium salt) is a soluble form of ursodeoxycholic acid which has antihyperlipidemia and gallbladder activity.

  • Adecatumumab

    Adecatumumab (MT201) is a whole-person IgG1 monoclonal antibody to human EpCAM. Adecatumumab has potential anticancer activity and can be used to study breast cancer.